Pierre Tambourin

Chief Executive Officer at Genopole Entreprises (Private Equity)

Pierre Tambourin

Pierre Tambourin

Chief Executive Officer at Genopole Entreprises (Private Equity)

Overview
Career Highlights

Genopole Entreprises (Private Equity)
Société d'Economie Mixte Genopole SAEM
Genopole

RelSci Relationships

116

Number of Boards

1

Relationships
RelSci Relationships are individuals Pierre Tambourin likely has professional access to. A relationship does not necessarily indicate a personal connection.

Managing Director at VantagePoint Management, Inc.

Relationship likelihood: Strong

Project Manager, Honorary Research Fellow-International at Genopole

Relationship likelihood: Strong

Communication Manager-Marketing & Public Relations at Genopole Entreprises (Private Equity)

Relationship likelihood: Strong

Chairman & Chief Executive Officer at Institut National de la Santé et de la Recherche Médicale

Relationship likelihood: Strong

Founder at Fujirebio Europe NV

Relationship likelihood: Strong

Co-Founder at Cardiawave SA

Relationship likelihood: Strong

Associate Professor at Hopital Necker-Enfants Malades

Relationship likelihood: Strong

Deputy Director General at International Vaccine Institute

Relationship likelihood: Strong

Former Chief Scientific Officer at Medicago, Inc.

Relationship likelihood: Strong

Chief Executive Officer at Nobel Web AB

Relationship likelihood: Strong

Paths to Pierre Tambourin
Potential Connections via
Relationship Science
You
Pierre Tambourin
Chief Executive Officer at Genopole Entreprises (Private Equity)
Career History
Chief Executive Officer
Current

Genopole Entreprises is the investment division of the French incubation platform Genopole®, which is specialized in genomics and post-genomics, and regroups teaching and research laboratories as well as startup incubation facilities and biotechnology companies. Genopole was founded by regional government entities.Genopole Entreprises is based in Evry on the south side of Paris and manages the G1J-Genopole 1er Jour Ile-de-France regional pre-seed fund (Genopole 1st Day), established in 1999. The firm aims to identify potential biotechnology entrepreneurs within public and private research laboratories. They invest public funds as well as a majority of private capital, both domestic and international. Investors include large corporations, regional government entities, financial institutions and private equity firms. They cooperate with Cap Décisif Management SAS, a Paris-based regional venture capital firm with a generalist approach.

Chief Executive Officer
Current

Société d'Economie Mixte Genopole SAEM is a company headquartered in Evry, and ultimately controlled by the Government of France. The firm provides real estate services. Pierre Tambourin is currently the CEO of the company.

Director of Research
Tenure Unconfirmed

Institut National de la Santé et de la Recherche Médicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

Boards & Committees
Member, Scientific Advisory Council
Current

Medicago, Inc. is a clinical-stage biopharmaceutical company. It develops novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The firm provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles and manufacturing technologies. It develops Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The company was founded by Louis-Philippe Vézina on July 17, 1997 and is headquartered in Quebec, Canada.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Pierre Tambourin. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Pierre Tambourin's profile does not indicate a business or promotional relationship of any kind between RelSci and Pierre Tambourin.